REAL WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENTS –USE OF ROUTINELY COLLECTED DATA TO ADDRESS EPIDEMIOLOGIC QUESTIONS IN KIDNEY TRANSPLANTATION IN THE AMNOG PROCESS IN GERMANY

Author(s)

Herrmann KH¹, Neubauer AS², Dombrowsky W¹, Koenig T³
¹Bristol-Myers Squibb, Munich, Germany, ²Institut für Gesundheitsökonomik München GbR, Munich, Germany, ³AQUA-Institut für angewandte Qualitätsförderung und Forschung, Goettingen, Germany

Presentation Documents

PUK23--strong-u-herrmann-kh-u-sup-1-sup-strong-neubauer-as-sup-2-sup-dombrowsky-w-sup-1-sup-koenig-t-sup-3-sup-br-sup-1-sup-bristol-myers-squibb-munich-germany-sup-2-sup-institut-fur-gesundheitsokonomik-munchen-gbr-munich-germany-sup-3-sup- ...

OBJECTIVES: To use routinely collected data for quality assurance (QA) in the German healthcare system mandated by the G-BA §137a SGBV, to obtain age distribution of donors and adult recipients for kidney-transplants. To determine the proportion of transplants classified from standard-criteria-donors (SCD) and from expanded-criteria-donors (ECD). METHODS:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PUK23

Topic

Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes

Disease

Urinary/Kidney Disorders

Explore Related HEOR by Topic

Health Technology Assessment

Presentation